{"id":167647,"date":"2025-03-31T05:17:45","date_gmt":"2025-03-31T09:17:45","guid":{"rendered":"https:\/\/44.250.171.167\/?p=167647"},"modified":"2025-03-31T05:17:45","modified_gmt":"2025-03-31T09:17:45","slug":"eris-lifesciences-ltd-q3fy25-14-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q3fy25-14-fall-in-profits\/","title":{"rendered":"ERIS Lifesciences Ltd Q3FY25; 14% fall in Profits"},"content":{"rendered":"<p>ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.<\/p>\n<p>Financial Results:<\/p>\n<p>ERIS Lifesciences Ltd reported Revenues for Q3FY25 of \u20b9727.00 Crores up from \u20b9486.00 Crore year on year, a rise of 49.59%.<\/p>\n<p>Total Expenses for Q3FY25 of \u20b9615.00 Crores up from \u20b9375.00 Crores year on year, a rise of 64.0%.<\/p>\n<p>Consolidated Net Profit of \u20b987.00 Crores down 13.86% from \u20b9101.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b96.14, down 18.68% from \u20b97.55 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-167648\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q3FY25 of \u20b9727.00 Crores up from \u20b9486.00 Crore year on year, a rise of 49.59%. Total Expenses for Q3FY25 of \u20b9615.00 Crores up from \u20b9375.00 Crores year on year, a rise of [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":167648,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-167647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/03\/L-12.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":169080,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q4fy25-28-rise-in-profits\/","url_meta":{"origin":167647,"position":0},"title":"ERIS Lifesciences Ltd Q4FY25; 28% rise in Profits","author":"Divyansh_Kasana","date":"July 10, 2025","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q4FY25 of \u20b9705.00 Crores up from \u20b9551.00 Crore year on year, a rise of 27.95%. Total Expenses for Q4FY25 of \u20b9584.00 Crores up from \u20b9489.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":166104,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q2fy25-21-fall-in-profits\/","url_meta":{"origin":167647,"position":1},"title":"ERIS Lifesciences Ltd Q2FY25; 21% fall in Profits","author":"Divyansh_Kasana","date":"December 18, 2024","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q2FY25 of \u20b9741.00 Crores up from \u20b9505.00 Crore year on year, a rise of 46.73%. Total Expenses for Q2FY25 of \u20b9616.00 Crores up from \u20b9382.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/PP.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/PP.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/PP.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/PP.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/PP.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/12\/PP.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":162460,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q4fy24-31-rise-in-profits\/","url_meta":{"origin":167647,"position":2},"title":"ERIS Lifesciences Ltd Q4FY24; 31% rise in Profits","author":"Divyansh_Kasana","date":"June 24, 2024","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q4FY24 of \u20b9551.00 Crores up from \u20b9403.00 Crore year on year, a rise of 36.72%. Total Expenses for Q4FY24 of \u20b9489.00 Crores up from \u20b9328.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-205.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":151417,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q1fy24-1-rise-in-profits\/","url_meta":{"origin":167647,"position":3},"title":"ERIS Lifesciences Ltd Q1FY24; 1% rise in Profits","author":"Hardik Bhandare","date":"August 7, 2023","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q1FY24 of \u20b9467.00 Crores up from \u20b9399.00 Crore year on year, a rise of 17.04%. Total Expenses for Q1FY24 of \u20b9355.00 Crores up from \u20b9299.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-246.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-246.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-246.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-246.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-246.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-246.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159968,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q3fy24-1-rise-in-profits\/","url_meta":{"origin":167647,"position":4},"title":"ERIS Lifesciences Ltd Q3FY24; 1% rise in Profits","author":"Divyansh_Kasana","date":"March 18, 2024","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q3FY24 of \u20b9486.00 Crores up from \u20b9423.00 Crore year on year, a rise of 14.89%. Total Expenses for Q3FY24 of \u20b9375.00 Crores up from \u20b9319.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-185.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-185.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-185.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-185.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-185.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-185.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":156995,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q2fy24-3-rise-in-profits\/","url_meta":{"origin":167647,"position":5},"title":"ERIS Lifesciences Ltd Q2FY24; 3% rise in Profits","author":"Divyansh_Kasana","date":"December 1, 2023","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q2FY24 of \u20b9505.00 Crores up from \u20b9461.00 Crore year on year, a rise of 9.54%. Total Expenses for Q2FY24 of \u20b9382.00 Crores up from \u20b9345.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=167647"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/167647\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/167648"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=167647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=167647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=167647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}